Lifecore Biomedical has secured three new customer agreements covering early- and late-stage development programs, including a late-stage regenerative medicine project and early-stage medical device formulation. These deals expand Lifecore's pipeline and are expected to contribute to revenue growth in 2028. The agreements highlight Lifecore's broad technical capabilities and position the company for sustained growth in high-demand markets like regenerative medicine and advanced medical technologies.
Bitcoin is expected to maintain a floor above $60,000, with potential to reach $1 million by 2030, driven by ongoing central bank money printing and liquidity conditions. Recent events like the Coldcard breach and BIP-110 fork test showed Bitcoin's r...
Publicly traded Bitcoin mining companies are reducing their mining capacity more quickly than the overall Bitcoin network as many shift resources toward AI and high-performance computing. This shift reflects a preference for more stable income stream...
Aave V3 now holds more than half of all tokenized gold deposits used as collateral in decentralized finance (DeFi), primarily through gold-backed tokens like PAXG and XAUT. This dominance highlights a shift toward using stable, commodity-backed asset...
US beef prices have surged by about 23% due to the smallest cattle herd in 75 years, currently at 86.2 million head, down from 94.7 million in 2019. Persistent drought has forced ranchers to reduce their herds, including breeding cows, delaying recov...
Bitcoin dropped from over $65,000 to just above $63,200 last week, influenced by Strategy's sale of 1,690 BTC. This decline led to a broader market pullback, with major altcoins like ADA and XRP also falling significantly. However, some tokens like C...
